» Articles » PMID: 38506738

Comparative Preclinical Assessment of Drug-coated Balloons: a Blessing and a Curse for Clinical Translation

Overview
Authors
Affiliations
Soon will be listed here.
References
1.
Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U . Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006; 355(20):2113-24. DOI: 10.1056/NEJMoa061254. View

2.
Kolodgie F, Pacheco E, Yahagi K, Mori H, Ladich E, Virmani R . Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine. J Vasc Interv Radiol. 2016; 27(11):1676-1685.e2. DOI: 10.1016/j.jvir.2016.06.036. View

3.
Neumann F, Sousa-Uva M, Ahlsson A, Alfonso F, Banning A, Benedetto U . 2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019; 14(14):1435-1534. DOI: 10.4244/EIJY19M01_01. View

4.
Aihara K, Torii S, Ito M, Koseki K, Shiozaki M, Sato Y . Biological differences of three paclitaxel- and sirolimus-coated balloons on coronary lesions in a rabbit model. EuroIntervention. 2024; 20(6):e389-e398. PMC: 10941670. DOI: 10.4244/EIJ-D-23-00425. View